TTY Biopharm Company Limited (4105.TWO)

TWD 72.7

(-0.41%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 9.87 Billion 9.6 Billion 9.29 Billion 9.36 Billion 9.55 Billion
Total Current Assets 5.37 Billion 5.03 Billion 4.74 Billion 4.79 Billion 4.97 Billion
Cash And Short Term Investments 2.81 Billion 2.68 Billion 2.59 Billion 2.56 Billion 2.57 Billion
Cash and Cash Equivalents 2.62 Billion 2.35 Billion 2.22 Billion 2.22 Billion 2.42 Billion
Short Term Investments 195.53 Million 326.86 Million 372.65 Million 342.4 Million 149.72 Million
Net Receivables 1.45 Billion 1.3 Billion 1.19 Billion 1.11 Billion 1.11 Billion
Inventory 1.09 Billion 1.03 Billion 955.01 Million 1.11 Billion 858.68 Million
Other Current Assets 6.36 Million 5.36 Million 1.15 Million 8.01 Million 378.18 Million
Total Non-Current Assets 4.5 Billion 4.56 Billion 4.54 Billion 4.56 Billion 4.57 Billion
Net PPE 2.3 Billion 2.43 Billion 2.52 Billion 2.58 Billion 2.59 Billion
Good Will And Intangible Assets 164 Million 250.74 Million 124.9 Million 132.89 Million 139.01 Million
Good Will - - - - -
Intangible Assets 164 Million - - - 139.01 Million
Long-Term Investments 1.53 Billion 1.31 Billion 1.2 Billion 1.26 Billion 1.74 Billion
Tax Assets 48.7 Million 47.09 Million 63.72 Million 61.79 Million 45.67 Million
Other Non Current Assets 454.36 Million 508.89 Million 621.97 Million 512.76 Million 53.35 Million
Other Assets - - - - -
Total Liabilities 3.36 Billion 3.36 Billion 3.52 Billion 3.28 Billion 3.38 Billion
Total Current Liabilities 2.58 Billion 2.91 Billion 3.05 Billion 2.54 Billion 3.02 Billion
Account Payables 238.53 Million 226.41 Million 130.03 Million 153.57 Million 179.82 Million
Tax Payables 156.96 Million 149.51 Million 150.39 Million 110.12 Million -
Short Term Debt 1.51 Billion 1.85 Billion 2.18 Billion 1.73 Billion 1.91 Billion
Deferred Revenue 816.94 Million 801.95 Million 712.24 Million 623.42 Million 16.67 Million
Other Current Liabilities 16.27 Million 33.3 Million 25.46 Million 34.18 Million 910.47 Million
Total Non Current Liabilities 785.02 Million 449.92 Million 477.65 Million 734.07 Million 358.22 Million
Long-Term Debt 403.04 Million 12.63 Million 18.3 Million 412.05 Million 16.31 Million
Deferred Revenue Non Current 27.4 Million 40.81 Million 52.59 Million 45.5 Million 1.00
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 35.82 Million 91.03 Million 146.22 Million 4.69 Million 59.83 Million
Other Liabilities - - - - -
Total Equity 6.5 Billion 6.23 Billion 5.76 Billion 6.07 Billion 6.16 Billion
Stock Holders Equity 5.94 Billion 5.65 Billion 5.16 Billion 5.44 Billion 5.57 Billion
Common Stock 2.48 Billion 2.48 Billion 2.48 Billion 2.48 Billion 2.48 Billion
Retained Earnings 1.59 Billion 1.44 Billion 1.23 Billion 1.55 Billion 1.59 Billion
Accumulated other comprehensive income 1.85 Billion - - - 1.49 Billion
Common Stock Equity 5.94 Billion 5.65 Billion 5.16 Billion 5.44 Billion 5.57 Billion
Capital Lease Obligation 8.91 Million 6.95 Million 21.78 Million - -
Total Investments 1.72 Billion 1.64 Billion 1.58 Billion 1.6 Billion 1.89 Billion
Total Debt 1.91 Billion 1.86 Billion 2.2 Billion 2.14 Billion 1.93 Billion
Net Debt -705.97 Million -488.94 Million -20.11 Million -74.2 Million -487.39 Million

Balance Sheet Charts